Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element
Journal Article
·
· European Journal of Medicinal Chemistry
- Wichita State Univ., Wichita, KS (United States)
- Kansas State Univ., Manhattan, KS (United States)
- Univ. of Iowa, Iowa City, IA (United States). Carver College of Medicine
- Univ. of Kansas, Lawrence, KS (United States)
- Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- LiS Consulting, Lawrence, KS (United States)
There are currently no approved vaccines or small molecule therapeutics available for the prophylaxis or treatment of Middle East Respiratory Syndrome coronavirus (MERS-CoV) infections. MERS-CoV 3CL protease is essential for viral replication; consequently, it is an attractive target that provides a potentially effective means of developing small molecule therapeutics for combatting MERS-CoV. We describe herein the structure-guided design and evaluation of a novel class of inhibitors of MERS-CoV 3CL protease that embody a piperidine moiety as a design element that is well-suited to exploiting favorable subsite binding interactions to attain optimal pharmacological activity and PK properties. Additionally, the mechanism of action of the compounds and the structural determinants associated with binding were illuminated using X-ray crystallography.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- Industrial Macromolecular Crystallography Association; KU Endowment Dolph Simons Award in Biomedical Sciences; National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
- Grant/Contract Number:
- AC02-06CH11357
- OSTI ID:
- 1433721
- Alternate ID(s):
- OSTI ID: 1548593
- Journal Information:
- European Journal of Medicinal Chemistry, Journal Name: European Journal of Medicinal Chemistry Journal Issue: C Vol. 150; ISSN 0223-5234
- Publisher:
- ElsevierCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease
Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
Journal Article
·
Sun Feb 07 19:00:00 EST 2016
· Journal of Medicinal Chemistry
·
OSTI ID:1248389
Structure-guided design of direct-acting antivirals that exploit the gem-dimethyl effect and potently inhibit 3CL proteases of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2) and middle east respiratory syndrome coronavirus (MERS-CoV)
Journal Article
·
Fri Apr 14 20:00:00 EDT 2023
· European Journal of Medicinal Chemistry
·
OSTI ID:2423799